COVID19 vaccine
Showing 1 - 25 of >10,000
Vaccine Hesitancy Trial (Multilevel Intervention)
Not yet recruiting
- Vaccine Hesitancy
- Multilevel Intervention
- (no location specified)
Nov 30, 2023
COVID-19 Trial (Recombinant variant COVID-19 vaccine (Sf9 cell), Recombinant COVID-19 vaccine (CHO cell), Recombinant COVID-19
Not yet recruiting
- COVID-19
- Recombinant variant COVID-19 vaccine (Sf9 cell)
- +2 more
- (no location specified)
Mar 10, 2023
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 2, 2023
SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10
Recruiting
- SARS-CoV-2 Infection
- Placebo
- +4 more
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Nov 7, 2023
A Study of the Effectiveness of Moderna COVID-19 Vaccine
Recruiting
- SARS-CoV-2
- COVID-19
- mRNA-1273
-
Pasadena, CaliforniaKaiser Permanente Southern California
Jul 5, 2023
Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior Trial (Baseline surveys, Digital Storytelling
Not yet recruiting
- Vaccine-Preventable Diseases
- +4 more
- Baseline surveys
- +2 more
- (no location specified)
Sep 12, 2023
Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination
Active, not recruiting
- Coronavirus Disease (COVID-19)
- COVID-19 Vaccine
-
Tokyo, JapanModerna selected site
Jan 12, 2023
COVID-19 Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-09), Inactivated COVID-19 vaccine (Vero cells))
Active, not recruiting
- COVID-19
- Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-09)
- Inactivated COVID-19 vaccine (Vero cells)
-
Seha, Abu Dhab, United Arab EmiratesSheikh Khalifa Medical City
Jan 31, 2023
Anti-COVID-19 Vaccine Side Effects
Completed
- Vaccine Adverse Reaction
- +2 more
-
Bari, BA, ItalyDepartment of Biomedical Sciences and Human Oncology - Clinica m
Feb 20, 2023
COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08), Inactivated
Recruiting
- COVID-19 Pneumonia
- Coronavirus Infections
- Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08)
- +2 more
-
Seha, Abu Dhab, United Arab EmiratesSheikh Khalifa Medical City
Jan 30, 2023
COVID-19 Trial (Recombinant variant COVID-19 vaccine(Sf9 cell))
Not yet recruiting
- COVID-19
- Recombinant variant COVID-19 vaccine(Sf9 cell)
- (no location specified)
Mar 10, 2023
COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)
Not yet recruiting
- COVID-19 Respiratory Infection
- COVID-19 Vaccine Adverse Reaction
- DNA vaccine OC-007
- Placebo
-
Stockholm, Region Stockholm, SwedenPhase I Study Unit, Karolinska University Hospital
Jan 13, 2023
Study of the Effectiveness of The COVID-19 Vaccine
Completed
- COVID-19
- COVID-19 Antibody
-
Sukoharjo, Central Java, IndonesiaUniversitas Sebelas Maret Hospital
Mar 9, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
Covid19, Vaccine Refusal, Vaccine Hesitancy Trial in New Orleans (COVID-19 Vaccine Education at the Point of COVID-19 Testing)
Recruiting
- Covid19
- +2 more
- COVID-19 Vaccine Education at the Point of COVID-19 Testing
-
New Orleans, LouisianaXavier University of Louisiana
Dec 19, 2022
Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
Completed
- COVID-19 Vaccine Adverse Reaction
- COVID-19 Vaccine questionnaire
-
Damanhūr, Elbehairah, EgyptRehab Hussein Werida
May 10, 2023
COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for
Recruiting
- COVID-19
- 1 Nebulized inhalation for booster groups
- +23 more
-
Xiangxi, Hunan, ChinaCDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
Oct 24, 2022
Immunogenicity of COVID-19 Vaccine in Inflammatory Bowel Disease
Completed
- IBD
- Covid19 Vaccine
- Serological Assay for SARS-CoV-2
-
Madison, WisconsinUniversity of Wisconsin
Dec 5, 2022
Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell
Recruiting
- Hematologic Diseases
- COVID-19 vaccine(donor)
- COVID-19 vaccine(patient)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 8, 2022
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E-2, SCTV01E)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E-2
- SCTV01E
- (no location specified)
Jul 4, 2023
COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)
Not yet recruiting
- COVID-19
- Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
-
Singapore, SingaporeNational University Hospital
Jan 29, 2023
Menstrual Irregularities and Abnormal Uterine Bleeding After
Completed
- COVID-19
- +3 more
- Covid-19 vaccine
-
Varese, ItalyUniversity of Insubria
Oct 31, 2022
COVID-19 Trial in Bengbu (Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell), Inactivated COVID-19 vaccine (Vero Cell))
Active, not recruiting
- COVID-19
- Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)
- Inactivated COVID-19 vaccine (Vero Cell)
-
Bengbu, Anhui, ChinaThe First Affiliated Hospital of Bengbu Medical College
Nov 3, 2022
Rheumatic Diseases, COVID-19 Vaccine, COVID-19 Trial in Chicago (COVID-19 vaccine and booster training, and importance)
Not yet recruiting
- Rheumatic Diseases
- +3 more
- COVID-19 vaccine and booster training, and importance
-
Chicago, IllinoisNorthwestern University
Apr 7, 2023
COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),
Recruiting
- COVID-19
- COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
- COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
-
Huai'an, Jiangsu, ChinaHuaiyin Center for Disease Control and Prevention
Jan 11, 2023